N5160
ナプロキセン ナトリウム
meets USP testing specifications
別名:
(S)-6-メトキシ-α-メチル-2-ナフタレン酢酸 ナトリウム塩
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
実験式（ヒル表記法）:
C14H13NaO3
CAS番号:
分子量:
252.24
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
41116107
EC Number:
247-486-2
MDL number:
Quality Level
agency
USP/NF, meets USP testing specifications
form
powder
application(s)
pharmaceutical (small molecule)
SMILES string
[Na+].COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O
InChI
1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1
InChI key
CDBRNDSHEYLDJV-FVGYRXGTSA-M
Gene Information
human ... PTGS1(5742), PTGS2(5743)
Biochem/physiol Actions
シクロオキシゲナーゼ(プロスタグランジHシンセターゼ1および2)インヒビターです。
Still not finding the right product?
Explore all of our products under ナプロキセン ナトリウム
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Repr. 1A
保管分類
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Arın Gül Dal et al.
Journal of analytical methods in chemistry, 2014, 352698-352698 (2014-10-09)
Simple and rapid capillary zone electrophoretic method was developed and validated in this study for the determination of piroxicam in tablets. The separation of piroxicam was conducted in a fused-silica capillary by using 10 mM borate buffer (pH 9.0) containing 10%
Rory W Blackler et al.
American journal of physiology. Gastrointestinal and liver physiology, 308(12), G994-1003 (2015-04-18)
The small intestine is a significant site of ulceration and bleeding induced by nonsteroidal anti-inflammatory drugs (NSAIDs). The pathogenesis is poorly understood. The present study explored the roles of bile, bacteria, and enterohepatic circulation to NSAID enteropathy, using both a
Matteo Morotti et al.
European journal of obstetrics, gynecology, and reproductive biology, 179, 63-68 (2014-06-27)
Evaluate patient satisfaction at 6-month treatment in women with symptomatic rectovaginal endometriosis and migraine without aura with (progestogen-only contraceptive pill, POP versus sequential combined oral contraceptives, COC) STUDY DESIGN: A patient preference trial including 144 women (82 in the group